Regulating Together for Autism
Trial Summary
What is the purpose of this trial?
This trial tests a program called Regulating Together, which helps children with autism manage their emotions. It targets kids aged 8-12 who struggle with emotional regulation. The program teaches them to recognize and control their feelings.
Will I have to stop taking my current medications?
The trial requires that families keep prescribed medications stable, so you won't need to stop taking your current medications.
What data supports the effectiveness of the treatment Achieving Independence and Mastery in School (AIMS) for autism?
How does the Regulating Together treatment for autism differ from other treatments?
The Regulating Together treatment is unique because it combines elements of social communication and self-regulation interventions, focusing on teaching these skills to both children with autism and their parents. This approach emphasizes parent involvement and aims to improve social communication and self-regulation knowledge, which is different from many other treatments that may not involve parents as actively.13678
Research Team
Rebecca Shaffer
Principal Investigator
Children's Hospital Medical Center, Cincinnati
Eligibility Criteria
This trial is for English-speaking caregivers and their children with autism spectrum disorder (ASD) who are 11-12 years old, have functional verbal communication, an IQ score of 65 or higher, and issues with emotion regulation. Families must commit to twice-weekly sessions and keep current medications stable. Children with major sensory impairments, recent psychosocial interventions, a history of serious aggression, or other major neuropsychiatric illnesses are excluded.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Baseline assessments are conducted
Treatment
Participants receive 5 weeks of intervention, twice per week
Post Active Treatment
Post-treatment assessments including semi-structured interviews
Post Generalization
Assessments to evaluate generalization of skills
Follow-up
Final outcome visit to monitor long-term effects
Treatment Details
Interventions
- Achieving Independence and Mastery in School (AIMS) (Behavioural Intervention)
- Regulating Together (RT) (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Children's Hospital Medical Center, Cincinnati
Lead Sponsor
Steve Davis
Children's Hospital Medical Center, Cincinnati
Chief Executive Officer since 2021
MD
Daniel Ostlie
Children's Hospital Medical Center, Cincinnati
Chief Medical Officer
MD from University of North Dakota
United States Department of Defense
Collaborator
Pete Hegseth
United States Department of Defense
Chief Executive Officer
Bachelor's degree in Political Science from Princeton University, JD from Harvard Law School
Lisa Hershman
United States Department of Defense
Chief Medical Officer since 2021
MD from Uniformed Services University of the Health Sciences
University of Alabama at Birmingham
Collaborator
Kierstin Kennedy
University of Alabama at Birmingham
Chief Medical Officer since 2022
MD
S. Dawn Bulgarella
University of Alabama at Birmingham
Chief Executive Officer since 2023
BSc in Commerce and Business Administration from the University of Alabama, MS in Health Administration from the University of Alabama at Birmingham